MedPath

The RAINBOW study: Rheumatoid Arthritis ImplemeNtation of Biological dose Optimization in real World

Suspended
Conditions
Rheumatoid Arthritis (RA)
Registration Number
NL-OMON22185
Lead Sponsor
This is an investigator-initiated study, funded by the Sint Maartenskliniek
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Suspended
Sex
Not specified
Target Recruitment
320
Inclusion Criteria

•Rheumatoid arthritis (clinical diagnosis of treating rheumatologist, fulfilled at any time point between start of the disease and inclusion) operationalized by DOT diagnosis 101.

•Being treated in a center in which the RAINBOW implementation project is starting

Exclusion Criteria

None

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath